tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Acrivon Therapeutics Inc

ACRV
Add to Watchlist
1.500USD
-0.020-1.32%
Close 07-31 16:00（ET）Quotes delayed by 15 min
58.12MMarket Cap
LossP/E TTM

Acrivon Therapeutics Inc

1.500
-0.020-1.32%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ACRV Financials

See Acrivon Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Acrivon Therapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.49/-0.53
Revenue / Forecast
--/276.67K
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.02
15.14%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
Financial Indicators
EPS
4.18%-0.49
17.68%-0.49
19.71%-0.47
-4.98%-0.55
29.68%-0.51
30.79%-0.60
10.11%-0.59
17.85%-0.52
-25.41%-0.73
-111.58%-0.86
---0.66
---0.63
---0.58
---0.41
---1.07
----
Net Profit
3.24%-19.04M
16.85%-18.98M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
----
Income Statement
Operating profit
8.12%-19.90M
19.39%-20.12M
21.69%-19.69M
-5.65%-22.65M
-22.61%-21.66M
-18.53%-24.95M
-55.79%-25.14M
-38.13%-21.44M
-22.75%-17.67M
-111.69%-21.05M
-68.53%-16.14M
---15.52M
---14.39M
---9.95M
---9.57M
----
Net Profit
3.24%-19.04M
16.85%-18.98M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
----
Balance Sheet
Current assets
-34.43%99.22M
-33.69%120.44M
-31.02%130.36M
-24.10%138.41M
34.94%151.33M
40.05%181.63M
30.79%188.98M
18.97%182.36M
-9.54%112.14M
-1.82%129.69M
83.66%144.49M
75.86%153.28M
--123.96M
--132.09M
--78.67M
--87.16M
Total current liabilities
-18.42%11.05M
-9.00%15.66M
0.49%14.89M
19.03%13.43M
49.87%13.55M
29.40%17.21M
59.36%14.82M
60.81%11.28M
59.12%9.04M
104.16%13.30M
45.50%9.30M
57.61%7.02M
--5.68M
--6.52M
--6.39M
--4.45M
Total assets
-38.85%107.83M
-34.02%129.72M
-32.32%145.30M
-31.23%158.58M
46.32%176.35M
42.18%196.59M
42.09%214.68M
44.07%230.59M
-29.19%120.52M
-23.71%138.26M
72.26%151.09M
68.48%160.05M
--170.20M
--181.23M
--87.71M
--95.00M
Total liabilities
-22.82%12.32M
-13.14%17.20M
-6.16%16.70M
7.01%15.55M
27.24%15.96M
16.00%19.80M
37.46%17.79M
33.70%14.53M
28.93%12.54M
58.78%17.07M
19.72%12.94M
20.00%10.87M
--9.73M
--10.75M
--10.81M
--9.05M
Total equity
-40.45%95.52M
-36.35%112.52M
-34.68%128.60M
-33.80%143.04M
48.54%160.39M
45.87%176.79M
42.52%196.89M
44.83%216.06M
-32.71%107.98M
-28.91%121.19M
79.64%138.15M
73.59%149.18M
--160.47M
--170.47M
--76.90M
--85.94M
Cash Flow Statement
Net operating income
-5.13%-20.54M
12.23%-15.24M
29.09%-12.28M
-19.47%-16.61M
-14.35%-19.54M
-40.38%-17.36M
-76.66%-17.32M
-52.58%-13.90M
-50.42%-17.08M
-32.20%-12.37M
-50.38%-9.81M
---9.11M
---11.36M
---9.35M
---6.52M
----
Net investment
-31.68%13.13M
49.35%21.52M
-63.08%5.91M
122.09%19.45M
228.44%19.21M
-29.82%14.41M
956.13%16.01M
-555.29%-88.04M
-37.28%5.85M
121.60%20.54M
103.36%1.52M
--19.34M
--9.33M
---95.07M
---45.12M
----
Net financing
90.38%-33.00K
70.32%-192.00K
92.22%-117.00K
-100.08%-97.00K
-99.42%-343.00K
67.83%-647.00K
-2028.21%-1.50M
32446.17%123.35M
---172.00K
-101.97%-2.01M
155.71%78.00K
--379.00K
--0.00
--101.86M
---140.00K
----

FAQs

What are the current assets of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its current assets were 120.44M, with a year-on-year change of -33.69.

What are the total assets of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its total assets of Acrivon Therapeutics Inc were 129.72M, with a year-on-year change of -34.02.

What are the total liabilities of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its total liabilities of Acrivon Therapeutics Inc were 17.20M, with a year-on-year change of -13.14.

What is the total equity of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its total equity of Acrivon Therapeutics Inc was 112.52M, with a year-on-year change of -36.35.

What is the net operating income of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its net operating income of Acrivon Therapeutics Inc was -84.11M, with a year-on-year change of 5.70.

What is the net investment of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its net investment of Acrivon Therapeutics Inc was 66.10M, with a year-on-year change of 227.68.

What is the net financing of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its net financing of Acrivon Therapeutics Inc was -749.00K, with a year-on-year change of -100.62.

What is the Earnings Per Share (EPS) of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.02, with a year-on-year change of 15.14.

What is the net income of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its net income was -77.91M, with a year-on-year change of 3.29.

What is the Return on Equity (ROE) of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -53.86, with a year-on-year change of 0.39.

What is the Return on Assets (ROA) of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -47.75, with a year-on-year change of 0.76.

What is the operating profit of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2025 earnings report, its operating profit was -84.11M, with a year-on-year change of 5.70.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy